MX2009011998A - Derivados de azetidina y su uso como antagonistas de prostaglandina e2. - Google Patents

Derivados de azetidina y su uso como antagonistas de prostaglandina e2.

Info

Publication number
MX2009011998A
MX2009011998A MX2009011998A MX2009011998A MX2009011998A MX 2009011998 A MX2009011998 A MX 2009011998A MX 2009011998 A MX2009011998 A MX 2009011998A MX 2009011998 A MX2009011998 A MX 2009011998A MX 2009011998 A MX2009011998 A MX 2009011998A
Authority
MX
Mexico
Prior art keywords
prostaglandin
antagonists
azetidine derivatives
antagonist
leiomyomata
Prior art date
Application number
MX2009011998A
Other languages
English (en)
Inventor
Sarah Elizabeth Skerratt
Neil Kevin Dack
Siew Kuen Yeap
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MX2009011998A publication Critical patent/MX2009011998A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a una clase de azetidinas antagonistas de EP2 de fórmula general (I) (ver fórmula (I)) en la que las variables y sustituyentes son como se definen en este documento, y especialmente a compuestos antagonistas de EP2, a su uso en medicina, particularmente en el tratamiento de endometriosis y/o miomas uterinos (leiomiomas) y a productos intermedios útiles en su síntesis y a composiciones que los contienen.
MX2009011998A 2007-05-10 2008-04-28 Derivados de azetidina y su uso como antagonistas de prostaglandina e2. MX2009011998A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91708107P 2007-05-10 2007-05-10
US1303007P 2007-12-12 2007-12-12
PCT/IB2008/001070 WO2008139287A1 (en) 2007-05-10 2008-04-28 Azetidine derivatives and their use as prostaglandin e2 antagonists

Publications (1)

Publication Number Publication Date
MX2009011998A true MX2009011998A (es) 2009-11-19

Family

ID=39739736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011998A MX2009011998A (es) 2007-05-10 2008-04-28 Derivados de azetidina y su uso como antagonistas de prostaglandina e2.

Country Status (27)

Country Link
US (1) US20080280877A1 (es)
EP (1) EP2155666A1 (es)
JP (1) JP2010526801A (es)
KR (1) KR20100009582A (es)
CN (1) CN101679235A (es)
AP (1) AP2009005047A0 (es)
AR (1) AR066524A1 (es)
AU (1) AU2008249744A1 (es)
BR (1) BRPI0811444A2 (es)
CA (1) CA2686517A1 (es)
CL (1) CL2008001305A1 (es)
CO (1) CO6260066A2 (es)
CR (1) CR11101A (es)
DO (1) DOP2009000256A (es)
EA (1) EA200901381A1 (es)
EC (1) ECSP099727A (es)
GT (1) GT200900293A (es)
IL (1) IL201874A0 (es)
MA (1) MA31366B1 (es)
MX (1) MX2009011998A (es)
PA (1) PA8779601A1 (es)
PE (1) PE20090282A1 (es)
SV (1) SV2009003407A (es)
TN (1) TN2009000470A1 (es)
TW (1) TW200904409A (es)
UY (1) UY31070A1 (es)
WO (1) WO2008139287A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222665A1 (en) * 2007-11-15 2010-09-01 Pfizer Limited Azetidines as ep2 antagonists
AP2011005728A0 (en) * 2008-11-10 2011-06-30 Pfizer Ltd Pyrrolidines.
JP2012522796A (ja) * 2009-04-02 2012-09-27 アラーガン インコーポレイテッド プロスタグランジンｅレセプター拮抗薬
DE102009049662A1 (de) 2009-10-13 2011-04-14 Bayer Schering Pharma Aktiengesellschaft 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten
WO2013010679A1 (en) 2011-07-15 2013-01-24 Novartis Ag Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
TW201326154A (zh) 2011-11-28 2013-07-01 拜耳知識產權公司 作為ｅｐ２受體拮抗劑之新穎２ｈ－吲唑
EP3237401B1 (en) 2014-12-22 2019-03-06 Pfizer Inc Antagonists of prostaglandin ep3 receptor
CN110041269A (zh) * 2019-05-16 2019-07-23 海门瑞一医药科技有限公司 一种2-氯-5-羟基嘧啶的制备方法
WO2022272062A1 (en) * 2021-06-24 2022-12-29 Reservoir Neuroscience, Inc. Ep2 antagonist compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300860D0 (en) * 1983-01-13 1983-02-16 Shell Int Research Azetidine compounds
GB8415614D0 (en) * 1984-06-19 1984-07-25 Shell Int Research Azetidine derivatives
GB8509746D0 (en) * 1985-04-16 1985-05-22 Shell Int Research Preparing azetidine derivatives
AR037364A1 (es) 2001-11-16 2004-11-03 Schering Corp Azetidinil diaminas utiles como ligandos del receptor de nociceptina orl-1
EA025871B9 (ru) * 2005-10-07 2017-08-31 Экселиксис, Инк. Ингибиторы mek и способы их применения
US8383660B2 (en) * 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives

Also Published As

Publication number Publication date
US20080280877A1 (en) 2008-11-13
CL2008001305A1 (es) 2008-07-18
EP2155666A1 (en) 2010-02-24
CN101679235A (zh) 2010-03-24
CO6260066A2 (es) 2011-03-22
AP2009005047A0 (en) 2009-12-31
BRPI0811444A2 (pt) 2014-10-29
EA200901381A1 (ru) 2010-06-30
IL201874A0 (en) 2010-06-16
SV2009003407A (es) 2010-01-12
TN2009000470A1 (fr) 2011-03-31
CA2686517A1 (en) 2008-11-20
ECSP099727A (es) 2009-12-28
TW200904409A (en) 2009-02-01
UY31070A1 (es) 2009-01-05
WO2008139287A1 (en) 2008-11-20
DOP2009000256A (es) 2009-11-30
JP2010526801A (ja) 2010-08-05
PA8779601A1 (es) 2009-01-23
MA31366B1 (fr) 2010-05-03
AU2008249744A1 (en) 2008-11-20
CR11101A (es) 2009-12-04
GT200900293A (es) 2010-05-17
PE20090282A1 (es) 2009-03-27
AR066524A1 (es) 2009-08-26
KR20100009582A (ko) 2010-01-27

Similar Documents

Publication Publication Date Title
MX2009011998A (es) Derivados de azetidina y su uso como antagonistas de prostaglandina e2.
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200870521A1 (ru) Замещенные спироциклические антагонисты cgrp-рецепторов
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
TN2009000107A1 (en) New sulfonamide derivatives as bradykinin antagonists
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
WO2009010871A3 (en) Pyrazole derivatives as antagonists of adenosine a3 receptor
EA200800540A1 (ru) Карбоксамидные производные в качестве антагонистов мускариновых рецепторов
ATE541839T1 (de) Pyrrolidiniumderivate als m3-muskarinische rezeptoren
EP1802372A4 (en) CGRP RECEPTOR ANTAGONISTS)
MY156324A (en) 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazole as 5-hydroxytryptamine-6 ligands
MX2009012518A (es) Derivados de piperidina 4,4-disubstituidos.
MX2009013775A (es) Sustituto novedoso de piperidones sustituidas como inductor de hsp.
EA201070532A1 (ru) Новые непептидные производные соединения в качестве b1 антагонистов брадикинина
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
IL206611A0 (en) Novel imidazolinylmethyl aryl sulfonamides
MX2010011767A (es) Derivados de benzocicloheptano y benzoxepina.
MX2010007928A (es) Imidazolinilmetil aril sulfonamidas novedosas.
IL206763A0 (en) Novel imidazolinylmethyl aryl sulfonamides
ATE373651T1 (de) 4-(aminomethyl)-piperidinbenzamide als 5ht4- antagonisten
ATE522530T1 (de) 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate
HK1121138A1 (en) Nk1 and nk2 antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal